Back
Rocket Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
RCKT
Rocket Pharmaceuticals, Inc.
Last Price:
$3.28
Seasonality Move:
-13.93%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing slight selling pressure.
Rocket Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.21 | Buy |
| 20-day SMA: | 3.45 | Sell |
| 50-day SMA: | 3.48 | Sell |
| 200-day SMA: | 3.61 | Sell |
| 8-day EMA: | 3.04 | Buy |
| 20-day EMA: | 2.18 | Buy |
| 50-day EMA: | 1.17 | Buy |
| 200-day EMA: | 0.34 | Buy |
Rocket Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 42.75 | Sell |
| Chaikin Money Flow: | -192037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.27 - 3.75) | Sell |
| Bollinger Bands (100): | (3.14 - 3.74) | Sell |
Rocket Pharmaceuticals, Inc. Technical Analysis
| Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals, Inc. Stock
Is Rocket Pharmaceuticals, Inc. Stock a Buy?
-
Rocket Pharmaceuticals, Inc. share price is 3.27 while RCKT 8-day simple moving average is 3.21, which is a Buy signal.
-
The stock price of RCKT is 3.27 while Rocket Pharmaceuticals, Inc. 20-day SMA is 3.45, which makes it a Sell.
-
Rocket Pharmaceuticals, Inc. 50-day simple moving average is 3.48 while RCKT share price is 3.27, making it a Sell technically.
-
RCKT stock price is 3.27 and Rocket Pharmaceuticals, Inc. 200-day simple moving average is 3.61, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
22
Rocket Pharmaceuticals, Inc. (RCKT)
is a Sell
Is Rocket Pharmaceuticals, Inc. a Buy or a Sell?
-
Rocket Pharmaceuticals, Inc. stock is rated a SellThe current Rocket Pharmaceuticals, Inc. [RCKT] share price is $3.27. The Score for RCKT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals, Inc. Stock Info
Market Cap:
353.9M
Price in USD:
3.27
Share Volume:
1.5M
Rocket Pharmaceuticals, Inc. 52-Week Range
52-Week High:
11.11
52-Week Low:
2.19
Sell
22
Rocket Pharmaceuticals, Inc. (RCKT)
is a Sell
Rocket Pharmaceuticals, Inc. Share Price Forecast
-
What is the Rocket Pharmaceuticals, Inc. stock price today?The Rocket Pharmaceuticals, Inc. stock price is 3.27 USD today.
-
Will RCKT stock go up or go down?Rocket Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rocket Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals, Inc. is overvalued.
Is Rocket Pharmaceuticals, Inc. Stock a Buy?
-
Rocket Pharmaceuticals, Inc. share price is 3.27 while RCKT 8-day exponential moving average is 3.04, which is a Buy signal.
-
The stock price of RCKT is 3.27 while Rocket Pharmaceuticals, Inc. 20-day EMA is 2.18, which makes it a Buy.
-
Rocket Pharmaceuticals, Inc. 50-day exponential moving average is 1.17 while RCKT share price is 3.27, making it a Buy technically.
-
RCKT stock price is 3.27 and Rocket Pharmaceuticals, Inc. 200-day simple moving average is 0.34, creating a Buy signal.
Fundamental Analysis of Rocket Pharmaceuticals, Inc.
Is Rocket Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Rocket Pharmaceuticals, Inc.
Should I short Rocket Pharmaceuticals, Inc. stock?
-
RCKT Moving Average Covergence Divergence (MACD) indicator is 0.87, suggesting Rocket Pharmaceuticals, Inc. is a Buy
-
Rocket Pharmaceuticals, Inc. Relative Strength Index (RSI) is 42.75, which suggest Rocket Pharmaceuticals, Inc. is oversold
-
The Bollinger Bands (25) for Rocket Pharmaceuticals, Inc. is (3.27 - 3.75), which suggest Rocket Pharmaceuticals, Inc. is a Sell
-
The Bollinger Bands (100) for Rocket Pharmaceuticals, Inc. is (3.14 - 3.74), which suggest Rocket Pharmaceuticals, Inc. is a Sell
* Rocket Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.